Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 76 of 76 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/01/16
End: 10/24/21
Due: 10/24/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes | NCT02962492 | University at Buffalo | user2@example.com | None | 2016-11-01 | 2021-10-24 | 2022-10-24 | - | - | 2025-07-14 |